Cargando…
Management of Pemphigus in COVID-19 Pandemic Era; a Review Article
The novel coronavirus is rapidly spreading around the world. Since the public announcement of the COVID-19 outbreak, several concerns have been raised by dermatologists as well as pemphigus patients who take immunosuppressive drugs. In this paper, we review the literature about the common treatment...
Autores principales: | Abdollahimajd, Fahimeh, Shahidi-Dadras, Mohammad, M Robati, Reza, Dadkhahfar, Sahar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shahid Beheshti University of Medical Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212074/ https://www.ncbi.nlm.nih.gov/pubmed/32440662 |
Ejemplares similares
-
Paraneoplastic Pemphigus with Underlying Retroperitoneal Inflammatory Myofibroblastic Tumor: A Case Report and Review of the Literature
por: Shahidi-Dadras, Mohammad, et al.
Publicado: (2017) -
Impact of COVID-19 Pandemic on Patients with Atopic Dermatitis
por: Pourani, M.R., et al.
Publicado: (2022) -
Can Immunofluorescence on Skin/Mucosal Scraping Smear for Pemphigus Diagnosis Substitute Direct Immunofluorescence on Skin Biopsy?
por: Shahidi Dadras, Mohammad, et al.
Publicado: (2022) -
COVID-19 Pandemic Impact on Severe Alopecia Areata Patients
por: Gheisari, Mehdi, et al.
Publicado: (2022) -
[Artículo traducido] Impacto de la pandemia de COVID-19 en los pacientes con dermatitis atópica
por: Pourani, M.R., et al.
Publicado: (2022)